Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
August 3, 2023 4:45 PM 2 min read

Lawmakers Press Biden To Address US Investment Risks In China: 'For Too Long, America Has Funded The China Communist Party's Military Buildup'

by Piero Cingari Benzinga Staff Writer
Follow

Rep. Mike Gallagher (R-WI), chairman of the House Select Committee on China, and other congressional members have penned a letter to President Joe Biden, expressing concerns over the draft executive order expected to restrict U.S. capital investment in critical technologies being developed in the People’s Republic of China (PRC).

Addressing The Risks

Rep. Gallagher acknowledges the necessity of addressing outbound investment but urges the president to adopt core principles that would tackle the national security issues at hand with the required urgency, clarity, and breadth.

He highlights the significant national security risk posed by U.S. investments in the PRC, which also expose Americans to financial risks and potentially implicate them in human rights abuses.

According to the American Enterprise Institute, over $200 billion of U.S. capital is invested in PRC companies through private markets, while over $1.1 trillion of American capital is invested through public markets in PRC stocks and bonds. This includes companies like Alibaba Group Holding Ltd (NYSE:BABA) and Tencent Holdings Ltd (OTC:TCEHY).

A considerable portion of this investment directly finances PRC technology companies with documented connections to the Chinese military and the Chinese Communist Party’s (CCP) human rights abuses.

Call for Transparency And Restrictions

Despite the clear risks, Rep. Gallagher points out that there is currently no mechanism for the U.S. Government to require disclosure of, or much less restrict, outbound capital flows to such foreign adversary companies. He urges the president to take meaningful first steps towards effective and balanced outbound investment rules.

He calls for transparency and a full accounting of total U.S. risk exposure and the final beneficiaries of U.S. investment in the PRC.

Gallagher also suggests that U.S. outbound investment rules should restrict problematic investments, guided by several core principles. This includes addressing both private and public market investments, restricting investments in sectors relevant to national security, safeguarding shareholder rights, providing certainty and predictability to investors and companies, and consulting allies and partners in advance.

“For too long, America has funded the China Communist Party (CCP)’s military buildup, technological ambitions, and human rights abuses and allowed the CCP unconstrained access to our capital markets and the dynamism and efficient capital allocation that they enable,” the chairman wrote.

This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Photo: Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


BABA Logo
BABAAlibaba Group Holding Ltd
$155.60-0.08%
Overview
FXI Logo
FXIiShares China Large-Cap ETF
Not Available-%
GXC Logo
GXCState Street SPDR S&P China ETF
$99.91-0.32%
TCEHY Logo
TCEHYTencent Holdings Ltd
$68.28-%
BABA Logo
BABAAlibaba Group Holding Ltd
$155.60-0.08%
Overview
FXI Logo
FXIiShares China Large-Cap ETF
Not Available-%
GXC Logo
GXCState Street SPDR S&P China ETF
$99.91-0.32%
TCEHY Logo
TCEHYTencent Holdings Ltd
$68.28-%
Comments
Loading...